| molecular function |
|---|
| | GO:0010181 | | FMN binding | | Interacting selectively and non-covalently with flavin mono nucleotide. Flavin mono nucleotide (FMN) is the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes. |
| | GO:0050661 | | NADP binding | | Interacting selectively and non-covalently with nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions; binding may be to either the oxidized form, NADP+, or the reduced form, NADPH. |
| | GO:0003785 | | actin monomer binding | | Interacting selectively and non-covalently with monomeric actin, also known as G-actin. |
| | GO:0034618 | | arginine binding | | Interacting selectively and non-covalently with 2-amino-5-(carbamimidamido)pentanoic acid. |
| | GO:0046870 | | cadmium ion binding | | Interacting selectively and non-covalently with cadmium (Cd) ions. |
| | GO:0005516 | | calmodulin binding | | Interacting selectively and non-covalently with calmodulin, a calcium-binding protein with many roles, both in the calcium-bound and calcium-free states. |
| | GO:0050660 | | flavin adenine dinucleotide binding | | Interacting selectively and non-covalently with FAD, flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes, in either the oxidized form, FAD, or the reduced form, FADH2. |
| | GO:0020037 | | heme binding | | Interacting selectively and non-covalently with heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring. |
| | GO:0005506 | | iron ion binding | | Interacting selectively and non-covalently with iron (Fe) ions. |
| | GO:0046872 | | metal ion binding | | Interacting selectively and non-covalently with any metal ion. |
| | GO:0004517 | | nitric-oxide synthase activity | | Catalysis of the reaction: L-arginine + n NADPH + n H+ + m O2 = citrulline + nitric oxide + n NADP+. |
| | GO:0016491 | | oxidoreductase activity | | Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0097110 | | scaffold protein binding | | Interacting selectively and non-covalently with a scaffold protein. Scaffold proteins are crucial regulators of many key signaling pathways. Although not strictly defined in function, they are known to interact and/or bind with multiple members of a signaling pathway, tethering them into complexes. |
| | GO:0034617 | | tetrahydrobiopterin binding | | Interacting selectively and non-covalently with a tetrahydrobiopterin, 5,6,7,8-tetrahydrobiopterin or a derivative thereof; tetrahydrobiopterins are enzyme cofactors that carry electrons in redox reactions. |
| biological process |
|---|
| | GO:0001525 | | angiogenesis | | Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. |
| | GO:0006527 | | arginine catabolic process | | The chemical reactions and pathways resulting in the breakdown of arginine, 2-amino-5-(carbamimidamido)pentanoic acid. |
| | GO:0001974 | | blood vessel remodeling | | The reorganization or renovation of existing blood vessels. |
| | GO:0045454 | | cell redox homeostasis | | Any process that maintains the redox environment of a cell or compartment within a cell. |
| | GO:0043542 | | endothelial cell migration | | The orderly movement of an endothelial cell into the extracellular matrix to form an endothelium. |
| | GO:0001701 | | in utero embryonic development | | The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus. |
| | GO:0031663 | | lipopolysaccharide-mediated signaling pathway | | A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system. |
| | GO:0030324 | | lung development | | The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax. |
| | GO:0007005 | | mitochondrion organization | | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a mitochondrion; includes mitochondrial morphogenesis and distribution, and replication of the mitochondrial genome as well as synthesis of new mitochondrial components. |
| | GO:0045776 | | negative regulation of blood pressure | | Any process in which the force of blood traveling through the circulatory system is decreased. |
| | GO:0051926 | | negative regulation of calcium ion transport | | Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of calcium ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| | GO:0008285 | | negative regulation of cell proliferation | | Any process that stops, prevents or reduces the rate or extent of cell proliferation. |
| | GO:1902042 | | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors | | Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors. |
| | GO:0051346 | | negative regulation of hydrolase activity | | Any process that stops or reduces the rate of hydrolase activity, the catalysis of the hydrolysis of various bonds. |
| | GO:0014740 | | negative regulation of muscle hyperplasia | | Any process that stops, prevents, or reduces the frequency, rate, or extent of muscle hyperplasia. |
| | GO:0010544 | | negative regulation of platelet activation | | Any process that decreases the rate or frequency of platelet activation. Platelet activation is a series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. |
| | GO:0043267 | | negative regulation of potassium ion transport | | Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of potassium ions (K+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| | GO:0006809 | | nitric oxide biosynthetic process | | The chemical reactions and pathways resulting in the formation of nitric oxide, nitrogen monoxide (NO), a colorless gas only slightly soluble in water. |
| | GO:0007263 | | nitric oxide mediated signal transduction | | Any intracellular signal transduction in which the signal is passed on within the cell via nitric oxide (NO). Includes synthesis of nitric oxide, receptors/sensors for nitric oxide (such as soluble guanylyl cyclase/sGC) and downstream effectors that further transmit the signal within the cell. Nitric oxide transmits its downstream effects through either cyclic GMP (cGMP)-dependent or independent mechanisms. |
| | GO:0001542 | | ovulation from ovarian follicle | | The process leading to the rupture of the follicle, releasing the centrally located oocyte into the oviduct. An example of this is found in Mus musculus. |
| | GO:0055114 | | oxidation-reduction process | | A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons. |
| | GO:0045766 | | positive regulation of angiogenesis | | Any process that activates or increases angiogenesis. |
| | GO:0031284 | | positive regulation of guanylate cyclase activity | | Any process that activates or increases the frequency, rate or extent of guanylate cyclase activity. |
| | GO:0008217 | | regulation of blood pressure | | Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure. |
| | GO:0050880 | | regulation of blood vessel size | | Any process that modulates the size of blood vessels. |
| | GO:0050999 | | regulation of nitric-oxide synthase activity | | Any process that modulates the activity of the enzyme nitric-oxide synthase. |
| | GO:0002028 | | regulation of sodium ion transport | | Any process that modulates the frequency, rate or extent of the directed movement of sodium ions (Na+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| | GO:0003100 | | regulation of systemic arterial blood pressure by endothelin | | The process in which endothelin modulates the force with which blood passes through the circulatory system. Endothelin is a hormone that is released by the endothelium, and it is a vasoconstrictor. |
| | GO:0003057 | | regulation of the force of heart contraction by chemical signal | | The regulation of the force of heart muscle contraction mediated by chemical signaling, hormonal, autocrine or paracrine. |
| | GO:0019430 | | removal of superoxide radicals | | Any process, acting at the cellular level, involved in removing superoxide radicals (O2-) from a cell or organism, e.g. by conversion to dioxygen (O2) and hydrogen peroxide (H2O2). |
| | GO:0034405 | | response to fluid shear stress | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fluid shear stress stimulus. Fluid shear stress is the force acting on an object in a system where the fluid is moving across a solid surface. |
| | GO:0009408 | | response to heat | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism. |
| | GO:0014806 | | smooth muscle hyperplasia | | A process, occurring in smooth muscle, in which there is an increase in cell number by cell division, often leading to an increase in the size of an organ. |
| cellular component |
|---|
| | GO:0005794 | | Golgi apparatus | | A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions. |
| | GO:0000139 | | Golgi membrane | | The lipid bilayer surrounding any of the compartments of the Golgi apparatus. |
| | GO:0005901 | | caveola | | A membrane raft that forms small pit, depression, or invagination that communicates with the outside of a cell and extends inward, indenting the cytoplasm and the cell membrane. Examples include flask-shaped invaginations of the plasma membrane in adipocytes associated with caveolin proteins, and minute pits or incuppings of the cell membrane formed during pinocytosis. Caveolae may be pinched off to form free vesicles within the cytoplasm. |
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0005856 | | cytoskeleton | | Any of the various filamentous elements that form the internal framework of cells, and typically remain after treatment of the cells with mild detergent to remove membrane constituents and soluble components of the cytoplasm. The term embraces intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles. |
| | GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| | GO:0030666 | | endocytic vesicle membrane | | The lipid bilayer surrounding an endocytic vesicle. |
| | GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| | GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| | GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
Description
